553 related articles for article (PubMed ID: 23664811)
1. Peptides and peptide-derived molecules targeting the intracellular domains of Cx43: gap junctions versus hemichannels.
Iyyathurai J; D'hondt C; Wang N; De Bock M; Himpens B; Retamal MA; Stehberg J; Leybaert L; Bultynck G
Neuropharmacology; 2013 Dec; 75():491-505. PubMed ID: 23664811
[TBL] [Abstract][Full Text] [Related]
2. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening.
Wang N; De Bock M; Decrock E; Bol M; Gadicherla A; Bultynck G; Leybaert L
Neuropharmacology; 2013 Dec; 75():506-16. PubMed ID: 24007825
[TBL] [Abstract][Full Text] [Related]
3. Emerging issues of connexin channels: biophysics fills the gap.
Harris AL
Q Rev Biophys; 2001 Aug; 34(3):325-472. PubMed ID: 11838236
[TBL] [Abstract][Full Text] [Related]
4. The contractile system as a negative regulator of the connexin 43 hemichannel.
Ponsaerts R; Wang N; Himpens B; Leybaert L; Bultynck G
Biol Cell; 2012 Jul; 104(7):367-77. PubMed ID: 22375941
[TBL] [Abstract][Full Text] [Related]
5. Intramolecular loop/tail interactions are essential for connexin 43-hemichannel activity.
Ponsaerts R; De Vuyst E; Retamal M; D'hondt C; Vermeire D; Wang N; De Smedt H; Zimmermann P; Himpens B; Vereecke J; Leybaert L; Bultynck G
FASEB J; 2010 Nov; 24(11):4378-95. PubMed ID: 20634352
[TBL] [Abstract][Full Text] [Related]
6. The SH3-binding domain of Cx43 participates in loop/tail interactions critical for Cx43-hemichannel activity.
Iyyathurai J; Wang N; D'hondt C; Jiang JX; Leybaert L; Bultynck G
Cell Mol Life Sci; 2018 Jun; 75(11):2059-2073. PubMed ID: 29218600
[TBL] [Abstract][Full Text] [Related]
7. Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone.
Yin X; Feng L; Ma D; Yin P; Wang X; Hou S; Hao Y; Zhang J; Xin M; Feng J
J Neuroinflammation; 2018 Mar; 15(1):97. PubMed ID: 29587860
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury.
Wang N; De Vuyst E; Ponsaerts R; Boengler K; Palacios-Prado N; Wauman J; Lai CP; De Bock M; Decrock E; Bol M; Vinken M; Rogiers V; Tavernier J; Evans WH; Naus CC; Bukauskas FF; Sipido KR; Heusch G; Schulz R; Bultynck G; Leybaert L
Basic Res Cardiol; 2013 Jan; 108(1):309. PubMed ID: 23184389
[TBL] [Abstract][Full Text] [Related]
9. In vivo analysis of undocked connexin43 gap junction hemichannels in ovarian granulosa cells.
Tong D; Li TY; Naus KE; Bai D; Kidder GM
J Cell Sci; 2007 Nov; 120(Pt 22):4016-24. PubMed ID: 17971414
[TBL] [Abstract][Full Text] [Related]
10. Regulation of connexin hemichannel activity by membrane potential and the extracellular calcium in health and disease.
Fasciani I; Temperán A; Pérez-Atencio LF; Escudero A; Martínez-Montero P; Molano J; Gómez-Hernández JM; Paino CL; González-Nieto D; Barrio LC
Neuropharmacology; 2013 Dec; 75():479-90. PubMed ID: 23587648
[TBL] [Abstract][Full Text] [Related]
11. Ischemia induces closure of gap junctional channels and opening of hemichannels in heart-derived cells and tissue.
Johansen D; Cruciani V; Sundset R; Ytrehus K; Mikalsen SO
Cell Physiol Biochem; 2011; 28(1):103-14. PubMed ID: 21865853
[TBL] [Abstract][Full Text] [Related]
12. Gap26, a connexin mimetic peptide, inhibits currents carried by connexin43 hemichannels and gap junction channels.
Desplantez T; Verma V; Leybaert L; Evans WH; Weingart R
Pharmacol Res; 2012 May; 65(5):546-52. PubMed ID: 22406236
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants underlying permeant discrimination of the Cx43 hemichannel.
Nielsen BS; Zonta F; Farkas T; Litman T; Nielsen MS; MacAulay N
J Biol Chem; 2019 Nov; 294(45):16789-16803. PubMed ID: 31554662
[TBL] [Abstract][Full Text] [Related]
14. Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential.
Retamal MA; Schalper KA; Shoji KF; Bennett MV; Sáez JC
Proc Natl Acad Sci U S A; 2007 May; 104(20):8322-7. PubMed ID: 17494739
[TBL] [Abstract][Full Text] [Related]
15. Connexin 43 and ischemic preconditioning.
Schulz R; Heusch G
Cardiovasc Res; 2004 May; 62(2):335-44. PubMed ID: 15094353
[TBL] [Abstract][Full Text] [Related]
16. Connexin-based gap junction hemichannels: gating mechanisms.
Sáez JC; Retamal MA; Basilio D; Bukauskas FF; Bennett MV
Biochim Biophys Acta; 2005 Jun; 1711(2):215-24. PubMed ID: 15955306
[TBL] [Abstract][Full Text] [Related]
17. Antibodies targeting extracellular domain of connexins for studies of hemichannels.
Riquelme MA; Kar R; Gu S; Jiang JX
Neuropharmacology; 2013 Dec; 75():525-32. PubMed ID: 23499293
[TBL] [Abstract][Full Text] [Related]
18. [Remodeling of cardiac gap junctions and arrhythmias].
Yu ZB; Sheng JJ
Sheng Li Xue Bao; 2011 Dec; 63(6):586-92. PubMed ID: 22193455
[TBL] [Abstract][Full Text] [Related]
19. Negatively charged residues (Asp378 and Asp379) in the last ten amino acids of the C-terminal tail of Cx43 hemichannels are essential for loop/tail interactions.
D'hondt C; Iyyathurai J; Wang N; Gourdie RG; Himpens B; Leybaert L; Bultynck G
Biochem Biophys Res Commun; 2013 Mar; 432(4):707-12. PubMed ID: 23376080
[TBL] [Abstract][Full Text] [Related]
20. At the cross-point of connexins, calcium, and ATP: blocking hemichannels inhibits vasoconstriction of rat small mesenteric arteries.
Bol M; Wang N; De Bock M; Wacquier B; Decrock E; Gadicherla A; Decaluwé K; Vanheel B; van Rijen HV; Krysko DV; Bultynck G; Dupont G; Van de Voorde J; Leybaert L
Cardiovasc Res; 2017 Feb; 113(2):195-206. PubMed ID: 27677282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
